Page last updated: 2024-08-23

ursodeoxycholic acid and Colorectal Cancer

ursodeoxycholic acid has been researched along with Colorectal Cancer in 63 studies

Research

Studies (63)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (3.17)	18.2507
2000's	27 (42.86)	29.6817
2010's	29 (46.03)	24.3611
2020's	5 (7.94)	2.80

Authors

Authors	Studies
Ahuja, N; Cai, Y; Gaule, P; Huang, H; Johnson, CH; Khan, SA; Lu, J; Lu, L; Muca, E; Paty, PB; Rattray, NJW; Rattray, Z; Shen, X; Theriot, CM; Yan, H; Zhang, Y	1
Adams-Haduch, J; Boffetta, P; Bui, NC; Clemente, JC; Ha, HT; Jia, W; Le, LC; Luu, HN; Nguyen, MV; Pham, HT; Schoen, RE; Thomas, CE; Tran, CT; Tran, MT; Tran, QH; Trinh, DT; Tuong, TT; Velikokhatnaya, L; Vu, HH; Wang, R; Xie, G; Yuan, JM	1
Blatkiewicz, M; Gutkowski, K; Kempinska-Podhorodecka, A; Krupa, L; Milkiewicz, M; Milkiewicz, P; Wunsch, E	1
Karlsen, TH; Vesterhus, M	1
Florea, A; Harris, RB; Jacobs, ET; Jurutka, PW; Klimentidis, YC; Kohler, LN	1
Kowdley, KV; Lashner, B; Rao, BB	1
Alberts, DS; Bilagody, C; Bokulich, NA; Caporaso, JG; Hornstra, H; Lance, P; Linhart, M; Martinez, JA; Padi, M; Pearson, T; Roe, DJ; Thompson, PA; Wertheim, BC; Yellowhair, M	1
Ardizzone, S; Danese, S; Gasche, C; Hernández, V; Kariv, R; Marti-Gallostra, M; Myrelid, P; Sebastian, S; Spinelli, A; Toruner, M; Tsianos, E; van der Meulen-de Jong, AE; Yuksel, ES	1
Khanna, S; Loftus, EV; Pardi, DS; Singh, S; Talwalkar, JA	1
Halai, UA; Hansen, JD; Kumar, S; Lo, WK; Poulsen, DM; Tater, KC	1
Han, SH; Lee, J	1
Galligan, MA; Hibler, EA; Jacobs, ET; Jurutka, PW; Sardo, CL; Stone, AD	1
Hibler, EA; Jacobs, ET; Jurutka, PW; Lance, P; Molmenti, CL	1
Chapman, CG; Rubin, DT	1
Leong, RW; Wang, R	1
Damm, R; Gademann, G; Hass, P; Kropf, S; Mohnike, K; Pech, M; Ricke, J; Sangro, B; Seidensticker, M; Seidensticker, R; Wust, P	1
Chang, JW; Chen, JS; Hsu, HC; Huang, WK; Kuo, CF; Lin, YC; Liu, JR; See, LC; Yang, TS; Yu, KH	1
Alberts, DS; Haussler, MR; Jacobs, ET; Jurutka, PW; Kohler, LN; Lance, P; Martínez, ME; Roe, DJ	1
Farinati, F; Herszényi, L; Miheller, P; Tulassay, Z	1
Alberts, DS; Hsu, CH; Long, Q; Taylor, JM	1
Chazouillères, O; Chrétien, Y; Corphechot, C; Garioud, A; Poupon, R; Poupon, RE; Seksik, P	1
Alberts, DS; Ashbeck, EL; Jacobs, ET; Lance, P; Martínez, ME; Roe, DJ; Thompson, PA; Wertheim, BC	1
Eksteen, B; Goh, J; Kane, K; Love, M; Low, A; Walt, R	1
Gotthardt, D; Kloeters-Plachky, P; Kulaksiz, H; Rost, D; Rudolph, G; Stiehl, A	1
Bissonnette, M; Poupon, R; Serfaty, L	1
Befeler, AS; Eaton, JE; Harnois, D; Harrison, ME; Jorgensen, R; Kowdley, KV; Lindor, KD; Luketic, VA; McCashland, T; Pardi, DS; Petz, J; Silveira, MG; Sinakos, E	1
Gotthardt, DN; Kloeters-Plachky, P; Kulaksiz, H; Rudolph, G; Schirmacher, P; Stiehl, A	1
Alberts, DS; Fang, C; Lance, P; Smith, JW; Thompson, PA; Wertheim, BC	1
Hsu, CH; Lance, P; Li, Y; Long, Q; Zhao, Q	1
Bazzoli, F; Ricciardiello, L; Solimando, R	1
Hibler, EA; Hu, C; Jacobs, ET; Jurutka, PW; Martinez, ME	1
Bergquist, A; Boberg, KM; Danielsson, A; Folvik, G; Friis-Liby, I; Gangsøy-Kristiansen, M; Hultcrantz, R; Lindström, L; Prytz, H; Rydning, A; Sandberg-Gertzén, H; Sangfelt, P; Wikman, O	1
Moreno-Otero, R; Santander, C	1
Bergquist, A; Boberg, KM; Castedal, M; Cvancarova, M; Foss, A; Friman, S; Holte, K; Isoniemi, H; Jørgensen, KK; Lindström, L; Nordin, A; Rasmussen, A; Schrumpf, E; Vatn, MH	1
Ponsioen, CY	1
Carey, EJ; Lindor, KD	1
Serfaty, L	1
Boersma-van Ek, W; de Vries, EG; Kleibeuker, JH; Termont, DS; van der Meer, R; van Gorkom, BA	1
Chazouilleres, O; De Leusse, A; Desaint, B; Flejou, JF; Poupon, R; Poupon, RE; Rosmorduc, O; Serfaty, L	1
Croog, VJ; Itzkowitz, SH; Ullman, TA	1
Courtney, ED; Leicester, RJ; Melville, DM	1
Diebold, J; Göke, B; Hay, U; Marsteller, I; Ochsenkühn, T; Paumgartner, G; Sackmann, M	1
Stiehl, A	1
Alberts, DS; Batta, AK; Chow, HH; Earnest, DL; Einspahr, J; Guillen, J; Hess, LM; Krutzsch, MF; Reid, ME; Salen, G	1
Kroesen, A; Pox, C; Schmiegel, W	1
Gill, S; Sinicrope, FA	1
Vetter, C	1
Alberts, DS; Batta, AK; Bhattacharyya, AK; Clouser, M; Einspahr, JG; Fales, L; Green, SB; Guillen, J; Hess, LM; Koonce, K; Krutzsch, M; Lance, P; Martínez, ME; Parish, D; Roe, D; Salen, G	1
Alberts, D; Bartels, HG; Bartels, PH; Einspahr, J; Frank, D; Lance, P; Ranger-Moore, J; Yozwiak, M	1
Lashner, BA; Rybicki, LA; Wolf, JM	1
Cao, M; Hanski, C; Hanski, ML; Jahreis, G; Keller, S; Loddenkemper, C; Stein, H; Zeitz, M	1
Bornet, F; Boutron-Ruault, MC; Franchisseur, C; Gerhardt, MF; Lavergne-Slove, A; Marteau, P; Myara, A	1
Alberts, DS; Giovannucci, E; Henning, SM; Jacobs, ET; Jiang, R; Martínez, ME; Smith-Warner, SA; Thompson, P	1
Green, SB; He, Y; Hsu, CH	1
Burakoff, R; Levine, JS	1
Alberts, DS; Ashbeck, EL; Jacobs, ET; Lance, P; Martínez, ME; Sinha, R; Thompson, PA	1
Arber, N; Boursi, B	1
Arber, N; Das, D; Jankowski, JA	1
Brasitus, TA	1
Narisawa, T	1
Lewis, JD	1
Gwyn, K; Sinicrope, FA	1

Reviews

21 review(s) available for ursodeoxycholic acid and Colorectal Cancer

Article	Year
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities. Journal of gastroenterology, 2020, Volume: 55, Issue:6 Topics: Bile Duct Neoplasms; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Clinical Trials as Topic; Colorectal Neoplasms; Humans; Liver Transplantation; Research Design; Severity of Illness Index; Ursodeoxycholic Acid	2020
Reviewing the Risk of Colorectal Cancer in Inflammatory Bowel Disease After Liver Transplantation for Primary Sclerosing Cholangitis. Inflammatory bowel diseases, 2018, 01-18, Volume: 24, Issue:2 Topics: Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Function Tests; Liver Transplantation; Mesalamine; Risk Factors; Ursodeoxycholic Acid	2018
Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I). Journal of Crohn's & colitis, 2014, Volume: 8, Issue:1 Topics: Age of Onset; Anticarcinogenic Agents; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Congresses as Topic; Crohn Disease; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunologic Factors; Mesalamine; Risk Factors; Survival Rate; Time Factors; Ursodeoxycholic Acid	2014
Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis. Inflammatory bowel diseases, 2013, Volume: 19, Issue:8 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Meta-Analysis as Topic; Prognosis; Ursodeoxycholic Acid	2013
Ursodiol and colorectal cancer or dysplasia risk in primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis. Digestive diseases and sciences, 2013, Volume: 58, Issue:11 Topics: Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Risk Factors; Ursodeoxycholic Acid	2013
[Chemoprevention of colorectal cancer in inflammatory bowel disease]. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 2014, Jan-25, Volume: 63, Issue:1 Topics: Anti-Inflammatory Agents; Chemoprevention; Colorectal Neoplasms; Folic Acid; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mesalamine; Ursodeoxycholic Acid	2014
The potential for medical therapy to reduce the risk of colorectal cancer and optimize surveillance in inflammatory bowel disease. Gastrointestinal endoscopy clinics of North America, 2014, Volume: 24, Issue:3 Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Early Detection of Cancer; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Intestinal Mucosa; Mercaptopurine; Mesalamine; Tumor Necrosis Factor-alpha; Ursodeoxycholic Acid	2014
Primary sclerosing cholangitis as an independent risk factor for colorectal cancer in the context of inflammatory bowel disease: a review of the literature. World journal of gastroenterology, 2014, Jul-21, Volume: 20, Issue:27 Topics: Anti-Inflammatory Agents; Anticarcinogenic Agents; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Prevalence; Prognosis; Risk Assessment; Risk Factors; Ursodeoxycholic Acid	2014
Chemoprevention of colorectal cancer: feasibility in everyday practice? European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2008, Volume: 17, Issue:6 Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Chemoprevention; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase 2 Inhibitors; Dietary Supplements; Family Practice; Feasibility Studies; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Mesalamine; Ursodeoxycholic Acid	2008
Ursodeoxycholic acid and chemoprevention of colorectal cancer. Gastroenterologie clinique et biologique, 2010, Volume: 34, Issue:10 Topics: Antineoplastic Agents; Chemoprevention; Colorectal Neoplasms; Cyclooxygenase 2; ErbB Receptors; Evidence-Based Medicine; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2010
Chemoprevention of colorectal cancer: a role for ursodeoxycholic acid, folate and hormone replacement treatment? Best practice & research. Clinical gastroenterology, 2011, Volume: 25, Issue:4-5 Topics: Animals; Anticarcinogenic Agents; Chemoprevention; Colorectal Neoplasms; Estrogen Replacement Therapy; Folic Acid; Humans; Treatment Outcome; Ursodeoxycholic Acid	2011
Recent insights in primary sclerosing cholangitis. Journal of digestive diseases, 2012, Volume: 13, Issue:7 Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholagogues and Choleretics; Cholangiocarcinoma; Cholangitis, Sclerosing; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Liver Transplantation; Ursodeoxycholic Acid	2012
Chemoprevention of colorectal cancer in ulcerative colitis. International journal of colorectal disease, 2003, Volume: 18, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium, Dietary; Chemoprevention; Cholagogues and Choleretics; Colitis, Ulcerative; Colorectal Neoplasms; Folic Acid; Hematinics; Humans; Mesalamine; Ursodeoxycholic Acid	2003
Review article: chemoprevention of colorectal cancer. Alimentary pharmacology & therapeutics, 2004, Jan-01, Volume: 19, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Calcium; Chemoprevention; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Dietary Fiber; Eflornithine; ErbB Receptors; Folic Acid; Humans; Life Expectancy; Mass Screening; Selenium; Ursodeoxycholic Acid	2004
[Primary sclerosing cholangitis]. Der Internist, 2004, Volume: 45, Issue:1 Topics: Bile Duct Neoplasms; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Comorbidity; Humans; Liver Function Tests; Prognosis; Risk Factors; Ursodeoxycholic Acid	2004
Colorectal cancer prevention: is an ounce of prevention worth a pound of cure? Seminars in oncology, 2005, Volume: 32, Issue:1 Topics: Adenoma; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Calcium; Clinical Trials as Topic; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Eflornithine; Folic Acid; Humans; Intestinal Mucosa; Selenium; Ursodeoxycholic Acid	2005
Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts. Inflammatory bowel diseases, 2007, Volume: 13, Issue:10 Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholagogues and Choleretics; Colorectal Neoplasms; Folic Acid; Humans; Immunosuppressive Agents; Inflammatory Bowel Diseases; Mercaptopurine; Mesalamine; Treatment Outcome; Ursodeoxycholic Acid; Vitamin B Complex	2007
Current and future clinical strategies in colon cancer prevention and the emerging role of chemoprevention. Current pharmaceutical design, 2007, Volume: 13, Issue:22 Topics: Alcohol Drinking; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Barium Compounds; Cell Transformation, Neoplastic; Chemoprevention; Colonoscopy; Colorectal Neoplasms; Contrast Media; Diet; Early Diagnosis; Enema; Exercise; Genetic Testing; Hormone Replacement Therapy; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Style; Mass Screening; Occult Blood; Patient Compliance; Risk Assessment; Risk Factors; Sigmoidoscopy; Smoking; Ursodeoxycholic Acid	2007
Chemoprevention of colorectal cancer. Digestion, 2007, Volume: 76, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Calcium Compounds; Chemoprevention; Colorectal Neoplasms; Cyclooxygenase Inhibitors; Dietary Fiber; Dietary Supplements; ErbB Receptors; Estrogen Replacement Therapy; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Selenium; Ursodeoxycholic Acid; Vitamin E	2007
[An overview on chemoprevention of colorectal cancer]. Nihon Geka Gakkai zasshi, 1998, Volume: 99, Issue:6 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carotenoids; Colorectal Neoplasms; Eflornithine; Fatty Acids, Omega-3; Humans; Ornithine Decarboxylase; Rats; Ursodeoxycholic Acid	1998
Chemoprevention of colorectal cancer. The American journal of gastroenterology, 2002, Volume: 97, Issue:1 Topics: Anti-Inflammatory Agents, Non-Steroidal; Ascorbic Acid; beta Carotene; Calcium Compounds; Colorectal Neoplasms; Dietary Fiber; Dietary Supplements; Eflornithine; Enzyme Inhibitors; Female; Folic Acid; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Prognosis; Risk Assessment; Sensitivity and Specificity; Ursodeoxycholic Acid; Vitamin E	2002

Trials

14 trial(s) available for ursodeoxycholic acid and Colorectal Cancer

Article	Year
Effects of ursodeoxycholic acid on the gut microbiome and colorectal adenoma development. Cancer medicine, 2019, Volume: 8, Issue:2 Topics: Adenoma; Aged; Colorectal Neoplasms; Feces; Female; Gastrointestinal Microbiome; Humans; Male; Middle Aged; Risk Factors; Ursodeoxycholic Acid	2019
Associations between circulating 1,25(OH)₂D concentration and odds of metachronous colorectal adenoma. Cancer causes & control : CCC, 2014, Volume: 25, Issue:7 Topics: Adenoma; Adult; Aged; Aged, 80 and over; Calcitriol; Cholagogues and Choleretics; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Male; Middle Aged; Odds Ratio; Risk Factors; Ursodeoxycholic Acid	2014
Prospective randomized trial of enoxaparin, pentoxifylline and ursodeoxycholic acid for prevention of radiation-induced liver toxicity. PloS one, 2014, Volume: 9, Issue:11 Topics: Aged; Aged, 80 and over; Brachytherapy; Colorectal Neoplasms; Enoxaparin; Female; Humans; Liver Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Pentoxifylline; Prospective Studies; Radiation Injuries; Ursodeoxycholic Acid	2014
Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer prevention research (Philadelphia, Pa.), 2016, Volume: 9, Issue:7 Topics: Adenoma; Adult; Aged; Bile Acids and Salts; Cholagogues and Choleretics; Colorectal Neoplasms; Cross-Sectional Studies; Feces; Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Ursodeoxycholic Acid; Vitamin D	2016
Gender modifies the effect of ursodeoxycholic acid in a randomized controlled trial in colorectal adenoma patients. Cancer prevention research (Philadelphia, Pa.), 2009, Volume: 2, Issue:12 Topics: Adenoma; Aged; Cholagogues and Choleretics; Colorectal Neoplasms; Female; Humans; Male; Placebos; Prognosis; Sex Factors; Treatment Outcome; Ursodeoxycholic Acid	2009
High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. The American journal of gastroenterology, 2011, Volume: 106, Issue:9 Topics: Adolescent; Adult; Aged; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Lithocholic Acid; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk; Ursodeoxycholic Acid; Young Adult	2011
Risk modification of colorectal adenoma by CYP7A1 polymorphisms and the role of bile acid metabolism in carcinogenesis. Cancer prevention research (Philadelphia, Pa.), 2012, Volume: 5, Issue:2 Topics: Adenoma; Aged; Cell Transformation, Neoplastic; Cholesterol 7-alpha-Hydroxylase; Colorectal Neoplasms; Double-Blind Method; Feces; Female; Humans; Male; Polymorphism, Single Nucleotide; Prognosis; Risk Factors; Ursodeoxycholic Acid	2012
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:4 Topics: Adolescent; Adult; Aged; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cohort Studies; Colorectal Neoplasms; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Sweden; Ursodeoxycholic Acid; Young Adult	2012
Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers. Scandinavian journal of gastroenterology, 2002, Volume: 37, Issue:8 Topics: Administration, Oral; Adult; Bile Acids and Salts; Cholagogues and Choleretics; Chromatography, Gas; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Cross-Over Studies; Double-Blind Method; Feces; Female; Hemolysis; Humans; Male; Middle Aged; Reference Values; Risk Factors; Ursodeoxycholic Acid	2002
Does ursodeoxycholic acid change the proliferation of the colorectal mucosa?. A randomized, placebo-controlled study. Digestion, 2003, Volume: 68, Issue:4 Topics: Adenoma; Aged; Cell Division; Cholagogues and Choleretics; Colon; Colorectal Neoplasms; Double-Blind Method; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Mucosa; Male; Middle Aged; Placebos; Rectum; Ursodeoxycholic Acid	2003
Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2004, Volume: 13, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Animals; Area Under Curve; Biological Availability; Colorectal Neoplasms; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Probability; Rats; Reference Values; Sex Factors; Ursodeoxycholic Acid	2004
Phase III trial of ursodeoxycholic acid to prevent colorectal adenoma recurrence. Journal of the National Cancer Institute, 2005, Jun-01, Volume: 97, Issue:11 Topics: Adenoma; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Treatment Outcome; Ursodeoxycholic Acid	2005
Karyometry in rectal mucosa of patients with previous colorectal adenomas. Analytical and quantitative cytology and histology, 2005, Volume: 27, Issue:3 Topics: Adenomatous Polyposis Coli; Algorithms; Bayes Theorem; Biomarkers; Biopsy; Cell Nucleus; Cholagogues and Choleretics; Colorectal Neoplasms; Discriminant Analysis; Double-Blind Method; Follow-Up Studies; Humans; Image Cytometry; Image Interpretation, Computer-Assisted; Intestinal Mucosa; Karyometry; Neoplasm Recurrence, Local; Prognosis; Rectum; Statistics, Nonparametric; Ursodeoxycholic Acid	2005
Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. International journal of cancer, 2006, Sep-15, Volume: 119, Issue:6 Topics: Adenoma; Aged; Colorectal Neoplasms; Diet; Dietary Fiber; Dietary Supplements; Double-Blind Method; Female; Folic Acid; Food, Fortified; Homocysteine; Humans; Male; Neoplasm Recurrence, Local; Risk Factors; Ursodeoxycholic Acid; Vitamin B Complex	2006

Other Studies

28 other study(ies) available for ursodeoxycholic acid and Colorectal Cancer

Article	Year
Bile acid distributions, sex-specificity, and prognosis in colorectal cancer. Biology of sex differences, 2022, 10-23, Volume: 13, Issue:1 Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Colonic Neoplasms; Colorectal Neoplasms; Female; Forkhead Transcription Factors; Glycochenodeoxycholic Acid; Humans; Lithocholic Acid; Male; Sex Distribution; Ursodeoxycholic Acid	2022
Associations between Ileal Juice Bile Acids and Colorectal Advanced Adenoma. Nutrients, 2023, Jun-28, Volume: 15, Issue:13 Topics: Adenoma; Bile Acids and Salts; Chenodeoxycholic Acid; Colorectal Neoplasms; Diabetes Mellitus, Type 2; Humans; Ursodeoxycholic Acid	2023
Oncomir MicroRNA-346 Is Upregulated in Colons of Patients With Primary Sclerosing Cholangitis. Clinical and translational gastroenterology, 2020, Volume: 11, Issue:1 Topics: Adult; Caco-2 Cells; Case-Control Studies; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colitis, Ulcerative; Colon; Colon, Ascending; Colon, Sigmoid; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p27; Female; Gene Expression Regulation; Hep G2 Cells; Humans; Male; MicroRNAs; Middle Aged; Receptors, Calcitriol; RNA, Ribosomal, 18S; Tumor Necrosis Factor-alpha; Up-Regulation; Ursodeoxycholic Acid; Young Adult	2020
Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma. Journal of gastrointestinal cancer, 2021, Volume: 52, Issue:3 Topics: Adenoma; Aged; Aged, 80 and over; Arizona; Cholagogues and Choleretics; Clinical Trials, Phase III as Topic; Colonic Polyps; Colorectal Neoplasms; Female; Fibroblast Growth Factors; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid	2021
Associations between vitamin D-binding protein isotypes, circulating 25(OH)D levels, and vitamin D metabolite uptake in colon cancer cells. Cancer prevention research (Philadelphia, Pa.), 2014, Volume: 7, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; DNA, Neoplasm; Double-Blind Method; Female; Genotype; Humans; Male; Middle Aged; Protein Isoforms; Randomized Controlled Trials as Topic; Real-Time Polymerase Chain Reaction; Receptors, Calcitriol; Tumor Cells, Cultured; Ursodeoxycholic Acid; Vitamin D; Vitamin D-Binding Protein	2014
The Association of Ursodeoxycholic Acid Use With Colorectal Cancer Risk: A Nationwide Cohort Study. Medicine, 2016, Volume: 95, Issue:11 Topics: Adult; Aged; Chemoprevention; Cholagogues and Choleretics; Cohort Studies; Colorectal Neoplasms; Databases, Factual; Female; Humans; Incidence; Liver Diseases; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Taiwan; Ursodeoxycholic Acid	2016
Analysis of colorectal adenoma recurrence data subject to informative censoring. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2009, Volume: 18, Issue:3 Topics: Adenoma; Cholagogues and Choleretics; Colonic Polyps; Colorectal Neoplasms; Disease Progression; Humans; Kaplan-Meier Estimate; Models, Statistical; Neoplasm Recurrence, Local; Prognosis; Ursodeoxycholic Acid	2009
Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study. European journal of gastroenterology & hepatology, 2010, Volume: 22, Issue:7 Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Cholangiocarcinoma; Cholangitis, Sclerosing; Cohort Studies; Colorectal Neoplasms; Female; France; Gallbladder Neoplasms; Humans; Incidence; Liver Failure; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Prognosis; Prospective Studies; Treatment Outcome; Ursodeoxycholic Acid; Young Adult	2010
Understanding of chemoprophylaxis and concordance in inflammatory bowel disease. World journal of gastroenterology, 2010, Feb-07, Volume: 16, Issue:5 Topics: Anti-Inflammatory Agents, Non-Steroidal; Cholagogues and Choleretics; Colorectal Neoplasms; Humans; Inflammatory Bowel Diseases; Male; Mesalamine; Patient Compliance; Patient Education as Topic; Surveys and Questionnaires; Treatment Outcome; Ursodeoxycholic Acid	2010
In PSC with dominant bile duct stenosis, IBD is associated with an increase of carcinomas and reduced survival. Journal of hepatology, 2010, Volume: 53, Issue:2 Topics: Adolescent; Adult; Aged; Bile Duct Neoplasms; Cholangitis, Sclerosing; Cholestasis; Colorectal Neoplasms; Comorbidity; Female; Follow-Up Studies; Gallbladder Neoplasms; Humans; Incidence; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Survival Rate; Ursodeoxycholic Acid; Young Adult	2010
In PSC with colitis treated with UDCA, most colonic carcinomas develop in the first years after the start of treatment. Digestive diseases and sciences, 2011, Volume: 56, Issue:12 Topics: Adolescent; Adult; Aged; Child; Cholagogues and Choleretics; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis, Sclerosing; Colonoscopy; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Germany; Humans; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Risk Factors; Time Factors; Ursodeoxycholic Acid; Young Adult	2011
Estimation of recurrence of colorectal adenomas with dependent censoring using weighted logistic regression. PloS one, 2011, Volume: 6, Issue:10 Topics: Adenoma; Colorectal Neoplasms; Computer Simulation; Databases as Topic; Female; Humans; Logistic Models; Male; Models, Biological; Monte Carlo Method; Placebos; Recurrence; Ursodeoxycholic Acid	2011
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2012, Volume: 21, Issue:2 Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Dietary Fiber; Double-Blind Method; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Middle Aged; Neoplasms, Second Primary; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid; Vitamin D; Vitamin D-Binding Protein	2012
Commentary: ursodeoxycholic acid as chemoprevention in inflammatory bowel disease and primary sclerosing cholangitis. Alimentary pharmacology & therapeutics, 2012, Volume: 35, Issue:7 Topics: Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Female; Humans; Male; Ursodeoxycholic Acid	2012
Colorectal neoplasia in patients with primary sclerosing cholangitis undergoing liver transplantation: a Nordic multicenter study. Scandinavian journal of gastroenterology, 2012, Volume: 47, Issue:8-9 Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Child; Child, Preschool; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colorectal Neoplasms; Female; Follow-Up Studies; Humans; Inflammatory Bowel Diseases; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Multivariate Analysis; Norway; Postoperative Period; Preoperative Period; Proportional Hazards Models; Risk Factors; Statistics, Nonparametric; Time Factors; Ursodeoxycholic Acid; Young Adult	2012
Chemoprevention of colorectal cancer with ursodeoxycholic acid: cons. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Antineoplastic Agents; Cholagogues and Choleretics; Colorectal Neoplasms; Humans; Ursodeoxycholic Acid	2012
Chemoprevention of colorectal cancer with ursodeoxycholic acid: pro. Clinics and research in hepatology and gastroenterology, 2012, Volume: 36 Suppl 1 Topics: Antineoplastic Agents; Chemoprevention; Cholagogues and Choleretics; Colorectal Neoplasms; Cyclooxygenase 2; ErbB Receptors; Evidence-Based Medicine; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Ursodeoxycholic Acid	2012
Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology (Baltimore, Md.), 2003, Volume: 38, Issue:1 Topics: Adenoma; Adult; Cell Division; Cholagogues and Choleretics; Colonoscopy; Colorectal Neoplasms; Female; Humans; Intestinal Mucosa; Liver Cirrhosis, Biliary; Male; Middle Aged; Neoplasm Recurrence, Local; Prevalence; Product Surveillance, Postmarketing; Risk Factors; Ursodeoxycholic Acid	2003
[Ulcerative colitis. Cancer prevention]. Zeitschrift fur Gastroenterologie, 2004, Volume: 42, Issue:9 Topics: Adenoma; Adenomatous Polyposis Coli; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Biopsy; Case-Control Studies; Child; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colectomy; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Cross-Sectional Studies; Female; Folic Acid; Follow-Up Studies; Humans; Male; Meta-Analysis as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; Ursodeoxycholic Acid	2004
[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?]. MMW Fortschritte der Medizin, 2005, Mar-31, Volume: 147, Issue:13 Topics: Anti-Inflammatory Agents, Non-Steroidal; Azathioprine; Cholangitis, Sclerosing; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Immunosuppressive Agents; Mesalamine; Recurrence; Risk Factors; Time Factors; Ursodeoxycholic Acid	2005
The impact of ursodeoxycholic acid on cancer, dysplasia and mortality in ulcerative colitis patients with primary sclerosing cholangitis. Alimentary pharmacology & therapeutics, 2005, Nov-01, Volume: 22, Issue:9 Topics: Adult; Age Factors; Age of Onset; Cholagogues and Choleretics; Cholangitis, Sclerosing; Cohort Studies; Colitis, Ulcerative; Colon; Colorectal Neoplasms; Female; Humans; Liver Transplantation; Male; Rectum; Risk Factors; Sex Factors; Ursodeoxycholic Acid	2005
Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid. International journal of cancer, 2006, Jun-01, Volume: 118, Issue:11 Topics: Administration, Oral; Animals; Bile Acids and Salts; Carcinoma; Cell Transformation, Neoplastic; Cholagogues and Choleretics; Colitis; Colon; Colorectal Neoplasms; Diet; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Ursodeoxycholic Acid	2006
Effects of a 3-mo consumption of short-chain fructo-oligosaccharides on parameters of colorectal carcinogenesis in patients with or without small or large colorectal adenomas. Nutrition and cancer, 2005, Volume: 53, Issue:2 Topics: Adenoma; Adult; Aged; Bile Acids and Salts; Biomarkers; Butyrates; Cell Division; Colonoscopy; Colorectal Neoplasms; Feces; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Oligosaccharides; Risk Factors; Ursodeoxycholic Acid	2005
A weighted logistic regression model for estimation of recurrence of adenomas. Statistics in medicine, 2007, Mar-30, Volume: 26, Issue:7 Topics: Adenoma; Cholagogues and Choleretics; Colonic Polyps; Colonoscopy; Colorectal Neoplasms; Computer Simulation; Humans; Kaplan-Meier Estimate; Logistic Models; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Treatment Refusal; Ursodeoxycholic Acid	2007
[Primary sclerosing cholangitis. To slow progression and reduce carcinoma risk]. MMW Fortschritte der Medizin, 2006, Jun-15, Volume: 148, Issue:24 Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colonic Neoplasms; Colorectal Neoplasms; Humans; Placebos; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Factors; Tablets; Time Factors; Ursodeoxycholic Acid	2006
Meat intake, preparation methods, mutagens and colorectal adenoma recurrence. Carcinogenesis, 2007, Volume: 28, Issue:9 Topics: Adenoma; Aged; Animals; Anticarcinogenic Agents; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Cooking; Double-Blind Method; Female; Humans; Male; Meat; Middle Aged; Mutagens; Odds Ratio; Recurrence; Regression Analysis; Risk Factors; Surveys and Questionnaires; Ursodeoxycholic Acid	2007
Primary chemoprevention strategies for colorectal cancer: ursodeoxycholic acid and other agents. Gastroenterology, 1995, Volume: 109, Issue:6 Topics: Animals; Chemoprevention; Colon; Colorectal Neoplasms; Deoxycholic Acid; Humans; Lithocholic Acid; Rats; Sulfates; Ursodeoxycholic Acid	1995
Ursodiol prevents UC-associated CRC. Gastroenterology, 2001, Volume: 121, Issue:2 Topics: Cholagogues and Choleretics; Colitis, Ulcerative; Colorectal Neoplasms; Humans; Ursodeoxycholic Acid	2001